Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Immunotherapy Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Melanoma
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Market Perspective (2018-2034)
2.2 Cancer Immunotherapy Growth Trends by Region
2.2.1 Global Cancer Immunotherapy Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Cancer Immunotherapy Historic Market Size by Region (2018-2023)
2.2.3 Cancer Immunotherapy Forecasted Market Size by Region (2024-2034)
2.3 Cancer Immunotherapy Market Dynamics
2.3.1 Cancer Immunotherapy Industry Trends
2.3.2 Cancer Immunotherapy Market Drivers
2.3.3 Cancer Immunotherapy Market Challenges
2.3.4 Cancer Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2018-2023)
3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Revenue
3.4 Global Cancer Immunotherapy Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2024
3.5 Cancer Immunotherapy Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Breakdown Data by Type
4.1 Global Cancer Immunotherapy Historic Market Size by Type (2018-2023)
4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2024-2034)
5 Cancer Immunotherapy Breakdown Data by Application
5.1 Global Cancer Immunotherapy Historic Market Size by Application (2018-2023)
5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Cancer Immunotherapy Market Size (2018-2034)
6.2 North America Cancer Immunotherapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Cancer Immunotherapy Market Size by Country (2018-2023)
6.4 North America Cancer Immunotherapy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Market Size (2018-2034)
7.2 Europe Cancer Immunotherapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Cancer Immunotherapy Market Size by Country (2018-2023)
7.4 Europe Cancer Immunotherapy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Market Size (2018-2034)
8.2 Asia-Pacific Cancer Immunotherapy Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Cancer Immunotherapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Immunotherapy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Market Size (2018-2034)
9.2 Latin America Cancer Immunotherapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Cancer Immunotherapy Market Size by Country (2018-2023)
9.4 Latin America Cancer Immunotherapy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Market Size (2018-2034)
10.2 Middle East & Africa Cancer Immunotherapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Cancer Immunotherapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Immunotherapy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Immunotherapy Introduction
11.1.4 Amgen Revenue in Cancer Immunotherapy Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Immunotherapy Introduction
11.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Cancer Immunotherapy Introduction
11.3.4 Roche Revenue in Cancer Immunotherapy Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Cancer Immunotherapy Introduction
11.4.4 Bayer Revenue in Cancer Immunotherapy Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2018-2023)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Cancer Immunotherapy Introduction
11.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Immunotherapy Introduction
11.7.4 Merck Revenue in Cancer Immunotherapy Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Cancer Immunotherapy Introduction
11.8.4 Novartis Revenue in Cancer Immunotherapy Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Cancer Immunotherapy Introduction
11.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2018-2023)
11.9.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immune Checkpoint Inhibitors
Table 4. Key Players of Immune System Modulators
Table 5. Key Players of Cancer Vaccines
Table 6. Global Cancer Immunotherapy Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Cancer Immunotherapy Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Cancer Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Immunotherapy Market Share by Region (2018-2023)
Table 10. Global Cancer Immunotherapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Cancer Immunotherapy Market Share by Region (2024-2034)
Table 12. Cancer Immunotherapy Market Trends
Table 13. Cancer Immunotherapy Market Drivers
Table 14. Cancer Immunotherapy Market Challenges
Table 15. Cancer Immunotherapy Market Restraints
Table 16. Global Cancer Immunotherapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Immunotherapy Market Share by Players (2018-2023)
Table 18. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2024)
Table 19. Ranking of Global Top Cancer Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cancer Immunotherapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Immunotherapy Product Solution and Service
Table 23. Date of Enter into Cancer Immunotherapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Immunotherapy Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Immunotherapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Table 29. Global Cancer Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Immunotherapy Revenue Market Share by Application (2018-2023)
Table 31. Global Cancer Immunotherapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Table 33. North America Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Cancer Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Cancer Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Cancer Immunotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Cancer Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cancer Immunotherapy Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Cancer Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Cancer Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 48. Amgen Company Detail
Table 49. Amgen Business Overview
Table 50. Amgen Cancer Immunotherapy Product
Table 51. Amgen Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 52. Amgen Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Cancer Immunotherapy Product
Table 56. AstraZeneca Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Cancer Immunotherapy Product
Table 61. Roche Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Cancer Immunotherapy Product
Table 66. Bayer Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Bristol-Myers Squibb Company Detail
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Cancer Immunotherapy Product
Table 71. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Eli Lilly Company Detail
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Cancer Immunotherapy Product
Table 76. Eli Lilly Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Merck Company Detail
Table 79. Merck Business Overview
Table 80. Merck Cancer Immunotherapy Product
Table 81. Merck Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Detail
Table 84. Novartis Business Overview
Table 85. Novartis Cancer Immunotherapy Product
Table 86. Novartis Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Detail
Table 89. Pfizer Business Overview
Table 90. Pfizer Cancer Immunotherapy Product
Table 91. Pfizer Revenue in Cancer Immunotherapy Business (2018-2023) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Immunotherapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Cancer Immunotherapy Market Share by Type: 2024 VS 2034
Figure 3. Monoclonal Antibodies Features
Figure 4. Immune Checkpoint Inhibitors Features
Figure 5. Immune System Modulators Features
Figure 6. Cancer Vaccines Features
Figure 7. Global Cancer Immunotherapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Cancer Immunotherapy Market Share by Application: 2024 VS 2034
Figure 9. Lung Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Colorectal Cancer Case Studies
Figure 12. Melanoma Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Cancer Immunotherapy Report Years Considered
Figure 16. Global Cancer Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Cancer Immunotherapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Cancer Immunotherapy Market Share by Region: 2024 VS 2034
Figure 19. Global Cancer Immunotherapy Market Share by Players in 2024
Figure 20. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2024
Figure 22. North America Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Cancer Immunotherapy Market Share by Country (2018-2034)
Figure 24. United States Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Canada Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Cancer Immunotherapy Market Share by Country (2018-2034)
Figure 28. Germany Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Asia-Pacific Cancer Immunotherapy Market Share by Region (2018-2034)
Figure 36. China Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Japan Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. South Korea Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. India Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Australia Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Latin America Cancer Immunotherapy Market Share by Country (2018-2034)
Figure 44. Mexico Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Brazil Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Cancer Immunotherapy Market Share by Country (2018-2034)
Figure 48. Turkey Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Saudi Arabia Cancer Immunotherapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 56. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed